L
Lei Dong
Researcher at Beijing Institute of Technology
Publications - 42
Citations - 3102
Lei Dong is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: Medicine & PTEN. The author has an hindex of 13, co-authored 33 publications receiving 2156 citations. Previous affiliations of Lei Dong include Shanghai University & Huazhong University of Science and Technology.
Papers
More filters
Journal ArticleDOI
Kidney disease is associated with in-hospital death of patients with COVID-19.
Yichun Cheng,Ran Luo,Kun Wang,Meng Zhang,Zhixiang Wang,Lei Dong,Junhua Li,Ying Yao,Shuwang Ge,Gang Xu +9 more
TL;DR: The findings show the prevalence of kidney disease on admission and the development of AKI during hospitalization in patients with COVID-19 is high and is associated with in-hospital mortality, and clinicians should increase their awareness of kidney patients with severe CO VID-19.
Journal ArticleDOI
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Lei Dong,Wen Mei Yu,Hong Zheng,Mignon L. Loh,Silvia T. Bunting,Melinda Pauly,Gang Huang,Muxiang Zhou,Hal E. Broxmeyer,David T. Scadden,Cheng-Kui Qu +10 more
TL;DR: It is reported that Ptpn11 activating mutations in the mouse bone marrow microenvironment promote the development and progression of MPN through profound detrimental effects on haematopoietic stem cells (HSCs), and CCL3 is identified as a potential therapeutic target for controlling leukaemic progression in Noonan syndrome and for improving stem cell transplantation therapy innoonan-syndrome-associated leukaemias.
Journal ArticleDOI
Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway.
TL;DR: It is found that cZNF292 silencing suppresses tube formation by inhibiting glioma cell proliferation and cell cycle progression via the Wnt/β-catenin signaling pathway and related genes.
Journal ArticleDOI
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.
Ke Xu,Guo Chen,Xiaobo Li,Xiaoqin Wu,Zhijie Chang,Jianhua Xu,Yu Zhu,Peihao Yin,Xin Liang,Lei Dong,Lei Dong +10 more
TL;DR: This study provides novel insights into the tumor progression associated with MFN2 deficiency and suggests that the importance of mTORC2 inhibitor in the treatment ofMFN2 downregulated cancer patients is suggested.
Journal ArticleDOI
Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease.
TL;DR: A review of recent advances on the potential role of NLRP3 inflammasome activation and its ability to alleviate liver inflammation in animal models provides critical targets to suppress the development of CLD in clinical management.